Arena Pharmaceuticals Stock News

Complete study of the global Lysosomal Storage Disease (LSD) market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding

LPL Financial LLC bought a new stake in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,991 shares of the biopharmaceutical companys stock, valued at approximately $204,000. Other hedge funds and other institutional investors also []

PARK CITY, Utah--(BUSINESS WIRE)---- $ARNA #ARNA--Arena achieved target enrollment in Study A of the CULTIVATE trial evaluating etrasimod in participants with moderate to severe Crohn''s disease.

Amalgamated Bank raised its stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 78.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,873 shares of the biopharmaceutical companys stock after acquiring an additional 3,891 shares during the period. Amalgamated Banks holdings in Arena []

H.C. Wainwright Stick to Their Buy Rating for Arena Pharmaceuticals

Arena Pharmaceuticals (ARNA) misses Q3 bottom-line estimates. The company progresses with pipeline development.

Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q3 2021 Results - Earnings Call Transcript

Arena Pharmaceuticals, Inc. (ARNA) delivered earnings and revenue surprises of -32.64% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead fo

After the recent FDA black box warning of JAKi, Arena Pharmaceuticals' share price has rallied recovering some of its 2021 losses. In this article, Etrasimod's ulcerative colitis phase 2 data will be

Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally. The post 7 Busted Biotech Stocks Due for a Rebound appeared first on

PARK CITY, Utah--(BUSINESS WIRE)--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted inducement stock options, inducement perf

Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2021 Results - Earnings Call Transcript

Arena Pharmaceuticals, Inc. (ARNA) delivered earnings and revenue surprises of -8.60% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue